Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 7Active not recruiting 3Not yet recruiting 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Genitourinary 1

Conditions

Breast Neoplasms 9Rectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Squamous Cell Carcinoma of Head and Neck 6Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Glioblastoma 4Esophageal Neoplasms 4Brain Neoplasms 4Neoplasms 3Nasopharyngeal Carcinoma 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Adenocarcinoma 2Spinal Cord Neoplasms 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1Rhabdomyosarcoma 1Rectal Cancer Patients 1Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pelvic Neoplasms 1

Interventions

Radiotherapy 2darolutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Intraductal, Noninfiltrating × Radiotherapy × Clear all
NCT07554573 2026-04-28

ABCD RT

NRG Oncology

Phase 3 Not yet recruiting
5,270 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT04176081 2024-01-24

SChLAP/IDC

University Health Network, Toronto

Phase 2 Not yet recruiting
208 enrolled
BreastGenitourinary

Carcinoma, Intraductal, Noninfiltrating, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡